Celera Revenues Drop 21 Percent in Q2 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celera's second-quarter revenues dropped almost 21 percent, it reported after the close of market on Tuesday, missing consensus Wall Street estimates.

For the three months ended June 26, Celera recorded $32.6 million in revenues, down from $41.4 million in Q2 2009, and short of the $36 million expected by analysts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.